Cellular immunity against recombinant vaccinia viruses expressing modificated E7 protein of human papillomavirus 16.

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F02%3A00000005" target="_blank" >RIV/00023736:_____/02:00000005 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Cellular immunity against recombinant vaccinia viruses expressing modificated E7 protein of human papillomavirus 16.

Original language description

Mice immunization experiments revealed that cell-mediated immunity and tumor growth protection after inoculation of virus expressing SigE7LAMP were stronger when used P13 strain than after MVA recombinant. Coexpression of IL-12 with SigE7LAMP did not improve the response.

Czech name

—

Czech description

—

Type

D - Article in proceedings

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

<a href="/en/project/GA301%2F00%2F0114" target="_blank" >GA301/00/0114: Dendritic cell based cancer vaccines</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2002

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Article name in the collection

20th international papillomavirus conference.

ISBN

—

ISSN

—

e-ISSN

—

Number of pages

1

Pages from-to

254

Publisher name

Institut Pasteur

Place of publication

Paris

Event location

Paris

Event date

Jan 1, 2002

Type of event by nationality

EUR - Evropská akce

UT code for WoS article

—